Purpose We aimed to quantify the relative risk of progression from mild cognitive impairment
(MCI) to dementia in people with and without diabetes, and with and without the MetS …

Aims As the potential impact of statins on cognitive decline and dementia is still debated, we
conducted a meta-analysis of observational studies to examine the effect of statin use on the …

Type 2 diabetes is associated with cognitive dysfunction and structural brain changes.
Abnormalities in glucose regulation are involved in several complications related to type 2 …

Type 2 diabetes is associated with dementia, and also with more slight cognitive
decrements. In this Review we discuss trajectories from normal cognition to dementia in …

Background: Despite the US Food and Drug Administration (FDA) warning regarding
cognitive impairment, the relationship between statins and cognition remains unknown …

We conducted a systematic review and meta-analysis to investigate whether the use of
statins could be associated with the risk of all-caused dementia, Alzheimer's disease (AD) …

Background Although patients with type 2 diabetes are twice as likely to develop dementia
as those without this disease, prediction of who has the highest future risk is difficult. We …

The risk of dementia is increased in people with type 2 diabetes mellitus (T2DM). This
review gives an update on the relation between T2DM and specific dementia subtypes–ie …

Background The association between long-term benzodiazepine use and risk of dementia
remains controversial. Therefore, current study aimed to quantify this association, and to …

Abstract Background and Aims: The impact of statin on dementia risk reduction has been a
subject of debate over the last decade, but the evidence remains inconclusive. Therefore …